Screener
ADMA Biologics ADMA PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 14,639 | 7,458 |
| Assets held for sale | - | 6,530 |
| Total current assets | 528,203 | 466,512 |
| Property and equipment, net | 66,664 | 65,057 |
| Intangible assets, net | 575 | 632 |
| Goodwill | 3,530 | 3,530 |
| Deferred tax assets, net | 69,965 | 73,261 |
| Right-of-use assets | 6,146 | 6,650 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's PP&E (net)?
- ADMA Biologics (ADMA) reported PP&E (net) of $66.66M in Q2 2026.
- How has ADMA Biologics's PP&E (net) changed year-over-year?
- ADMA Biologics's PP&E (net) increased by 15.9% year-over-year, from $57.5M to $66.66M.
- What is the long-term trend for ADMA Biologics's PP&E (net)?
- Over 5 years (2020 to 2025), ADMA Biologics's PP&E (net) has grown at a 9.4% compound annual growth rate (CAGR), from $41.59M to $65.06M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about ADMA Biologics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude